📌 Key Takeaways
Debate continues over MedSpa regulation in Texas
Physician delegation rules for cosmetic injections remain in place
Rapid growth of the MedSpa industry is raising broader regulatory questions
Debate over the regulation of medical spas (MedSpas) continues in the state of Texas.
In recent months, some industry discussions suggested that Texas had “closed a MedSpa loophole” and significantly tightened oversight of aesthetic procedures.
However, according to a clarification issued by aesthetic training provider MySpaLive, the core legal framework governing cosmetic injections has not fundamentally changed.
Under current Texas law, cosmetic injections remain classified as the practice of medicine, and physicians may continue to delegate certain medical procedures to properly trained professionals under supervision.
The current debate appears to reflect regulatory clarification rather than a major statutory shift.
INDEX
FACT CHECK | What Happened
Industry discussions intensified in early 2026 after claims circulated that Texas had significantly tightened MedSpa regulations.
According to MySpaLive, however, the legislative developments cited in some reports did not change the legal structure governing cosmetic injections.
Proposed MedSpa legislation did not become law
A bill introduced in 2025 that sought to strengthen oversight of MedSpa practices did not become law after the governor vetoed it.
As a result, the current framework allowing physicians to delegate certain medical procedures to trained providers remains unchanged under Texas medical law.
New law focuses on IV therapy
Another law that took effect in September 2025 addresses elective IV therapy services, rather than cosmetic injections.
Therefore, procedures such as:
neurotoxin injections (e.g., Botox)
dermal fillers
are not directly affected by the new legislation.
ISSUE | How MedSpas Are Regulated
Under Texas law, cosmetic injections are considered the practice of medicine.
However, physicians may delegate certain medical acts to qualified providers if specific regulatory requirements are met.
These requirements typically include:
A Good Faith Examination before treatment
Physician supervision or oversight
Written treatment protocols
Emergency preparedness such as Basic Life Support (BLS) capability
As a result, MedSpas operate as medical services delivered under physician oversight, rather than independent cosmetic service businesses.
INDUSTRY IMPACT | A Rapidly Growing Market
The regulatory debate is occurring as the MedSpa market continues to expand rapidly in the United States.
Medical spas now offer a wide range of services including:
laser treatments
cosmetic injections
medical weight-loss programs
Industry analysts estimate the MedSpa sector is growing at double-digit annual rates.
This expansion has raised broader questions around:
the scope of physician supervision
qualification requirements for injectors
medical liability and accountability
Another key issue is that MedSpa regulations vary significantly by state, creating a fragmented regulatory landscape across the United States.
Some industry groups have begun calling for greater national standardization of MedSpa regulations.
EDITOR’S POINT | Where Medicine Meets Aesthetic Services
The rapid growth of MedSpas reflects a structural shift in aesthetic medicine.
Historically, cosmetic procedures were delivered primarily within traditional medical clinics.
Today, however, the market increasingly blends:
medical practice
and
consumer-facing aesthetic services.
Determining where the boundary lies between these two domains is becoming a central regulatory challenge.
The debate surrounding MedSpa regulation may ultimately shape how the future architecture of aesthetic medicine is defined.
Summary
-
Debate continues over MedSpa regulation in Texas
-
Physician delegation rules for cosmetic injections remain unchanged
-
The U.S. MedSpa market continues to expand rapidly
-
Regulatory differences between states remain a major industry issue
Sources
Business Wire
Texas Medical Board
MySpaLive
NERO’s Mission
NERO reports on global developments in aesthetic medicine
through the lens of structure, ethics, and long-term consequence.
Rather than amplifying surface-level trends,
we examine how medical practices are regulated, commercialised, and normalised —
and what is reshaped when innovation moves faster than existing frameworks.
As aesthetic medicine expands beyond traditional clinical boundaries,
NERO focuses on the grey zones where definitions blur, responsibilities shift,
and medical decision-making becomes increasingly complex.
In an era of accelerating innovation,
NERO remains committed to transparency, critical scrutiny,
and responsible reporting —
so readers can understand not only what is new,
but what deserves closer examination before it becomes standard practice.
